Monday, December 23, 2024
HomeTagsCRISPR Therapy

CRISPR Therapy

FDA Clears SNIPR BIOME’s Investigational New Drug Application for SNIPR001, Targeting E. coli Infections

SNIPR BIOME ApS, a leading CRISPR and microbiome biotechnology company, is pleased to announce that the US Food and Drug Administration (FDA) has approved...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics